These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6987787)

  • 1. Serum inhibitors of in vitro hematopoiesis and graft outcome in bone marrow transplantation for aplastic anemia.
    Fitchen JH; Gale RP; Cline MJ
    Transplantation; 1980 Mar; 29(3):223-6. PubMed ID: 6987787
    [No Abstract]   [Full Text] [Related]  

  • 2. Preceding transfusions and marrow graft rejection in dogs and man.
    Weiden PL; Storb R; Thomas ED; Graham TC; Lerner KG; Buckner CD; Fefer A; Neiman PE; Clift RA
    Transplant Proc; 1976 Dec; 8(4):551-4. PubMed ID: 793113
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin--long-term results.
    Mathé G; Schwarzenberg L
    Transplant Proc; 1976 Dec; 8(4):595-602. PubMed ID: 136773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for the use of ALG as sole immunosuppressant in allogeneic bone marrow transplantation for aplastic anemia.
    Speck B; Buckner CD; Cornu P; Jeannet B
    Transplant Proc; 1976 Dec; 8(4):617-22. PubMed ID: 11593
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrence of aplastic anemia following cyclophosphamide and syngeneic bone marrow transplantation: evidence for two mechanisms of graft failure.
    Appelbaum FR; Cheever MA; Fefer A; Storb R; Thomas ED
    Blood; 1985 Mar; 65(3):553-6. PubMed ID: 3882169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation in 65 patients with severe aplastic anemia.
    Gluckman E; Devergie A; Gerotta I; Hors J; Sasportes M; Boiron M; Bernard J
    Bull Cancer; 1981; 68(1):74-7. PubMed ID: 7013871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors.
    Deeg HJ; Anasetti C; Petersdorf E; Storb R; Doney K; Hansen JA; Sanders J; Sullivan KM; Appelbaum FR
    Blood; 1994 Jun; 83(11):3417-8. PubMed ID: 8193380
    [No Abstract]   [Full Text] [Related]  

  • 8. Selection of patients for bone marrow transplantation in severe aplastic anemia.
    Camitta BM; Rappeport JM; Parkman R; Nathan DG
    Blood; 1975 Mar; 45(3):355-63. PubMed ID: 1090310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation for aplastic anemia.
    Ramsay NK; Storb R
    Prog Clin Biol Res; 1984; 148():291-5. PubMed ID: 6379666
    [No Abstract]   [Full Text] [Related]  

  • 10. Marrow graft rejection and inhibition of growth in culture by serum in aplastic anaemia.
    Barrett AJ; Faille A; Saal F; Balitrand N; Gluckman E
    J Clin Pathol; 1978 Dec; 31(12):1244-8. PubMed ID: 372246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation for severe aplastic anemia in Japan.
    Kanamaru A; Nagai K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():495-500. PubMed ID: 6394812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful bone marrow transplantation in sensitized recipients.
    Levey RH; Parkman R; Rappeport J; Nathan DG; Rosen F
    Transplant Proc; 1979 Mar; 11(1):199-204. PubMed ID: 377631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late graft rejection following allogeneic bone marrow transplantation in aplastic anemia.
    Rodriguez V; Khan SP
    Transplant Proc; 2002 Jun; 34(4):1307-9. PubMed ID: 12072347
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.
    Smith BR; Guinan EC; Parkman R; Ferrara J; Levey RH; Nathan DG; Rappeport JM
    Transplantation; 1985 Jun; 39(6):671-3. PubMed ID: 3890295
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation for severe aplastic anemia from HLA identical siblings.
    Bacigalupo A
    Haematologica; 1999 Jan; 84(1):2-4. PubMed ID: 10091385
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of bone marrow aplasia by allogenic bone marrow grafts].
    Gluckman E; Bussel A; Benbunan M; Broquet MA; Schaison G; Dausset J; Bernard J
    Nouv Presse Med; 1975 Apr; 4(16):1177-82. PubMed ID: 240152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case problems in bone marrow transplantation. I. Graft failure in aplastic anemia: its biology and treatment.
    Champlin RE; Feig SA; Gale RP
    Exp Hematol; 1984 Oct; 12(9):728-33. PubMed ID: 6386510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of colony forming assays to bone marrow transplanation with particular reference to grafting for aplastic anaemia.
    Gordon MY
    Br J Haematol; 1979 May; 42(1):61-71. PubMed ID: 37884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hematopoietic changes following allogeneic bone marrow graft in idiopathic aplastic anemia].
    Kigasawa H; Toyoda Y; Hanada R; Nishihira H; Nagao T
    Rinsho Ketsueki; 1983 Nov; 24(11):1539-43. PubMed ID: 6368899
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation for the treatment of severe aplastic anaemia.
    Spruce W; McMillan R; Beutler E
    Clin Haematol; 1983 Feb; 12(1):285-310. PubMed ID: 6340884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.